Picture EBD Group BioTech Showcase 2021 Whitepaper Presenting 650x80
Document › Details

Metabolomic Discoveries GmbH. (4/25/14). "Press Release: Filgen to Distribute Metabolomic Discoveries’ Technologies in Japan". Potsdam.

Region Region Japan
Organisations Organisation Metabolomic Discoveries GmbH
  Group Metabolon (Group)
  Organisation 2 Filgen Inc. (JP)
Products Product metabolomic technology
  Product 2 metabolomic services
Index term Index term Filgen–Metabolomic Discoveries: metabolomics, 201404– distribution excl of Metabolomic Discoveries’ technologies in Japan by Filgen
Persons Person Schauer, Nicolas (Biocrates 201909– Co-CEO + CSO before Metabolomic Discoveries Managing Director + Founder)
  Person 2 Harada, Manabu (Filgen Inc 201404 Manager of Bioscience Dept)

Metabolomic Discoveries and Filgen sign Distributorship Agreement

Metabolomic Discoveries and Filgen Inc. have signed an exclusive distributorship agreement for Metabolomic Discoveries' technologies in Japan. This is the first step to enter the Japanese market and both companies have strong belief in the potential of metabolomics for research purposes, product development and quality control in Japan.

Nicolas Schauer, CEO of Metabolomic Discoveries, is pleased with the agreement: 'I believe Filgen is an excellent match to our company and has the skills and experience to expand our business in Japan. Personally, I have a very special relationship with Japan and I have great respect for the innovation power and professionalism of Japanese research.' Manabu Harada, Manager of the Bioscience Department of Filgen, adds: 'The collaboration agreement with Metabolomic Discoveries gives us the opportunity to expand our offer of biotechnology services to our customers. It is becoming increasingly clear that metabolomics should be a constant part of their research programs'.

Metabolomic Discoveries is a leading research and analytical service company based in Potsdam, Germany. The company provides comprehensive metabolite analysis metabolomics in biological systems and the identification of biomarkers. In addition, the objective pursued by Metabolomic Discoveries is the qualitative improvement of life by combining analytical and bigdata approaches with biological expertise. For further information please visit

Filgen is a Japan based company offering biotechnology analysis services as well as research reagents and bioinformatics software. Specifically, these services include LCMS/MS(iTRAQ), next generation sequencing, DNA microarrays, real time PCR and other advanced technologies. Filgen supports research in the field of advanced biotechnology.


Metabolomic Discoveries GmbH
Marleen van Balkom
T +49 331 951 43881 /

Filgen Inc.
Manabu Harada
T +81 52 624 4388 /

Metabolomic Discoveries GmbH · Am Mühlenberg 11 · 14476 Potsdam · Germany, +49 (0)331 951 43881 Geschäftsführung: Dr. Nicolas Schauer · HRB 22137 P · Amtsgericht Potsdam USt.:
DE266143989 · Bankverbindung: MBS Potsdam SWIFT/BIC: WELADED1PMB IBAN: DE09160500003502029902

Record changed: 2019-06-09


Picture [iito] No Tracking 650x80px

More documents for Metabolon (Group)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture EBD Group BioTech Showcase 2021 Digital Event BTS2021 651x81

» top